Indian unit of AstraZeneca up on Pfizer offer for parent
Reuters Market Eye - Shares of Astrazeneca Pharma India Ltd , the Indian unit of AstraZeneca Plc , rise 2.5 percent as the British drugmaker is approached by Pfizer Inc for a potential $100 billion takeover.
Astrazeneca Pharma India shares have gained 53 percent since January on speculation that its parent would be a takeover candidate.
Astrazeneca Plc holds a 75 percent stake in its Indian subsidiary, BSE data shows.
(abhishek.vishnoi@thomsonreuters.com / abhishek.vishnoi.thomsonreuters.com@reuters.net)